Viracta Therapeutics Stock Quote VIRX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.2275

Bid

0.225

Ask

0.2275

Volume

15,854,831

0.00 Day's Range 0.00

0.1315 52 Week Range 1.31

Market Cap

9.042M

Previous Close

0.1628

Open

Last Trade

1527

0.2275

(formt)

Last Trade Time

04:44:35

Financial Volume

VWAP

Average Volume (3m)

1,303,606

Shares Outstanding

39,744,222

Dividend Yield

PE Ratio

-0.12

Earnings Per Share (EPS)

-1.28

Revenue

Net Profit

-51.06M

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.viracta.com

Headquarters

Wilmington, Delaware, USA

Founded

Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.16. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.1315 to $ 1.31.

Viracta Therapeutics currently has 39,744,222 shares outstanding. The market capitalization of Viracta Therapeutics is $6.47 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.12.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

- Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data...

Form 8-K - Current report

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0849	59.5371669004	0.1426	0.2948	0.1326	3819158	0.15843741	CS
4	0.0315	16.0714285714	0.196	0.2948	0.1315	1952899	0.17063373	CS
12	-0.0047	-2.0241171404	0.2322	0.2972	0.1315	1303606	0.20174754	CS
26	-0.4825	-67.9577464789	0.71	0.8201	0.1315	922926	0.2580233	CS
52	-0.2525	-52.6041666667	0.48	1.31	0.1315	527181	0.31065463	CS
156	-3.8925	-94.4781553398	4.12	5.75	0.1315	293913	1.23484736	CS
260	-16.5325	-98.642601432	16.76	18.24	0.1315	290455	2.89010007	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CNEYCN Energy Group Inc	$ 0.8279 (162.33%)	13.34M
HTOOFusion Fuel Green PLC	$ 0.6128 (92.70%)	3.16M
HRTXHeron Therapeautics Inc	$ 2.12 (79.66%)	7.66M
VIRXViracta Therapeutics Inc	$ 0.217 (33.29%)	12.74M
OMEXOdyssey Marine Exploration Inc	$ 0.5267 (25.37%)	3.71M
ORISOriental Rise Holdings Ltd	$ 6.90 (-42.26%)	13.11k
MOFGMidWestOne Financial Group	$ 26.50 (-19.21%)	100
THRDThird Harmonic Bio Inc	$ 9.01 (-19.05%)	128
FSTRL B Foster Company	$ 24.00 (-18.51%)	107
ZJKZJK Industrial Company Ltd	$ 14.18 (-17.84%)	93.08k
CNEYCN Energy Group Inc	$ 0.8279 (162.33%)	13.34M
VIRXViracta Therapeutics Inc	$ 0.217 (33.29%)	12.74M
HRTXHeron Therapeautics Inc	$ 2.12 (79.66%)	7.66M
OMEXOdyssey Marine Exploration Inc	$ 0.5267 (25.37%)	3.71M
HTOOFusion Fuel Green PLC	$ 0.6128 (92.70%)	3.16M